| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/08/2000 | WO2000032625A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 06/08/2000 | WO2000032239A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 06/08/2000 | WO2000032231A1 Stimulation of t cells against self antigens using ctla-4 blocking agents |
| 06/08/2000 | WO2000032229A1 Preparations containing virus-like particles as immunopotentiators administered through the mucosa |
| 06/08/2000 | WO2000032228A2 Peptide-based vaccine for influenza |
| 06/08/2000 | WO2000032227A2 Ordered molecular presentation of antigens, method of preparation and use |
| 06/08/2000 | WO2000032226A2 Xenograft animal model for the induction of papillomas, the production of papillomavirus and the propagation thereof |
| 06/08/2000 | WO2000032221A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | WO2000032212A1 Lak activity potentiator orginating in shiitake mushroom hyphae extract and lak activity potentiating preparations containing the same |
| 06/08/2000 | WO2000032205A1 Immunomodulatory methods using carbohydrate antigens |
| 06/08/2000 | WO2000032168A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases |
| 06/08/2000 | WO2000032047A1 Plasmid maintenance system for antigen delivery |
| 06/08/2000 | WO2000015659A3 Stomach polypeptide zsig28 |
| 06/08/2000 | WO2000012535A3 Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof |
| 06/08/2000 | WO2000011191A3 Tpl-2/cot kinase and methods of use |
| 06/08/2000 | WO2000011183A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/08/2000 | WO2000010580A3 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders |
| 06/08/2000 | WO2000008191A3 Herpes virus vectors for dendritic cells |
| 06/08/2000 | WO2000004137A9 Human aspartic proteases |
| 06/08/2000 | WO1999033475A8 Galactosylceramide, glucosylceramide, lactosylceramide, and specific catchers therefor for use in the prophylaxis or therapy of prediabetes, diabetes and/or associated complications |
| 06/08/2000 | DE19832840C1 Mittel zur Immuntherapie von Tumorerkrankungen Means for immunotherapy of tumors |
| 06/08/2000 | CA2566516A1 Psca: prostate stem cell antigen and uses thereof |
| 06/08/2000 | CA2354183A1 Ordered molecular presentation of antigens, method of preparation and use |
| 06/08/2000 | CA2353502A1 Immunomodulatory methods using carbohydrate antigens |
| 06/08/2000 | CA2353304A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
| 06/08/2000 | CA2353107A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/08/2000 | CA2352759A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 06/08/2000 | CA2352738A1 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 06/08/2000 | CA2352487A1 Utilisation of capsules containing one or more antigenic substances for the prevention and/or treatment of autoimmune diseases |
| 06/08/2000 | CA2352466A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 06/08/2000 | CA2352457A1 Plasmid maintenance system for antigen delivery |
| 06/08/2000 | CA2352454A1 Peptide-based vaccine for influenza |
| 06/08/2000 | CA2347835A1 Promotion or inhibition of angiogenesis and cardiovascularization |
| 06/08/2000 | CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2000 | EP1006197A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells |
| 06/07/2000 | EP1006194A2 C-erbB-2 external domain: GP75 |
| 06/07/2000 | EP1006182A2 Polypeptide fragments of factor VIIIC, corresponding probes and DNA sequences and DNA constructs |
| 06/07/2000 | EP1005870A2 Therapeutic application of chimeric antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma |
| 06/07/2000 | EP1005552A1 Member of the hematopoietin receptor superfamily |
| 06/07/2000 | EP1005550A1 Ubc7-like ubiquitin-conjugating enzyme |
| 06/07/2000 | EP1005546A2 Compounds for immunotherapy of prostate cancer and methods for their use |
| 06/07/2000 | EP1005543A2 Human herpesvirus - 7 diagnostic and immunologic reagents and uses thereof |
| 06/07/2000 | EP1005535A1 Attenuation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 06/07/2000 | EP1005494A1 High avidity polyvalent and polyspecific reagents |
| 06/07/2000 | EP1005487A1 The 74 kilodalton outer membrane protein from moraxella catarrhalis |
| 06/07/2000 | EP1005372A1 Anti-cd40l immunotoxins for the treatment of diseases |
| 06/07/2000 | EP1005371A2 Method and food product for increasing muscle protein and reducing fat in animals |
| 06/07/2000 | EP1005368A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
| 06/07/2000 | EP1005367A2 Vaccines containing bordetella pertussis antigen |
| 06/07/2000 | EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 06/07/2000 | EP1005365A1 Abundant extracellular products and methods for their production and use |
| 06/07/2000 | EP1005364A1 Method of protecting against chronic infections |
| 06/07/2000 | EP1005363A2 Recombinant dimeric envelope vaccine against flaviviral infection |
| 06/07/2000 | EP1005356A1 Novel antibacterial agents |
| 06/07/2000 | CN1255927A Human neuroglia mature factor (GMF) beta homologous gene (CBFBOE11) |
| 06/07/2000 | CN1255862A Use of avian antibodies |
| 06/07/2000 | CN1255861A Multivalent vaccine compsn. with mixed carrier |
| 06/07/2000 | CN1255860A Immunogenic compsns to CCK-b/gastrin-receptor and methods for treatment of tumors |
| 06/07/2000 | CN1255378A Monoclonal antibody Fab'-Pingyangmycin conjugate and its anticancer action |
| 06/06/2000 | US6072049 Hepatitis B surface antigen vaccine |
| 06/06/2000 | US6072048 DNA molecule encoding for cellular uptake of Mycobacterium tuberculosis and uses thereof |
| 06/06/2000 | US6072039 Hybrid polypeptide comparing a biotinylated avidin binding polypeptide fused to a polypeptide of interest |
| 06/06/2000 | US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections |
| 06/06/2000 | US6072028 Amino acid sequence of effector cell protease receptor-1, a transmembrane glycoprotein receptor for factor xa; immunosuppressants for autoimmune disorders; suppression or activation of lymphocyte proliferation; diagnosis of disease |
| 06/06/2000 | US6071942 Elevation of circulating blood histamine levels |
| 06/06/2000 | US6071894 Sensor histidine kinase of Staphylococcus aureus |
| 06/06/2000 | US6071893 Administering to the mammal a polynucleotide encoding a fusion glycoprotein of respiratory syncytial viurs in combination with an effective amount of adjuvant interleukin-12 for reducing replication of respiratory syncytial virus |
| 06/06/2000 | US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein |
| 06/06/2000 | US6071891 Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition |
| 06/06/2000 | US6071747 Human preadipocytes for developing antiobesity and antidiabetic agents; cells include immortalizing fragment of viral oncogene, promoter from viral oncogene or human vimentin gene, and express certain proteins |
| 06/06/2000 | US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines |
| 06/06/2000 | US6071737 Equine Neospora isolate and its uses |
| 06/06/2000 | US6071736 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus |
| 06/06/2000 | US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents |
| 06/06/2000 | US6071705 Method of detecting neurological disease or dysfunction |
| 06/06/2000 | US6071697 Method for testing the differentiation status in pancreatic cells of a mammal |
| 06/06/2000 | US6071693 HCV genomic sequences for diagnostics and therapeutics |
| 06/06/2000 | US6071692 Inserting exogenous genes into cells; inserting gene into plasmid and transforming cell |
| 06/06/2000 | US6071538 Oral delivery composition comprising supramolecular complex |
| 06/06/2000 | US6071522 Cloning of mite allergens |
| 06/06/2000 | US6071520 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 06/06/2000 | US6071519 Treating autoimmune diseases, hodgkin's disease and other lymph cancers |
| 06/06/2000 | US6071518 GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium |
| 06/06/2000 | US6071516 Administering normal gamma-globulin |
| 06/06/2000 | US6071514 Administering activated protein c and antiplatelet agent and/or anticoagulant |
| 06/06/2000 | CA2132547C Vaccines containing non-ionic surfactant vesicles |
| 06/06/2000 | CA2073778C Enzyme treated bcg vaccine and process therefor |
| 06/06/2000 | CA1341020C Lipoprotein i (ompi) of pseudomonas aeruginosa |
| 06/06/2000 | CA1341015C Outer membrane protein f of pseudomonas aeruginosa |
| 06/06/2000 | CA1341014C Hcg peptides for use in antibody purification procedures |
| 06/06/2000 | CA1341013C Compositions and methods for clones containing dna sequences associated with multidrug resistance in human cells |
| 06/02/2000 | WO2000031270A1 Bartonella proteins and uses thereof |
| 06/02/2000 | WO2000031263A2 Gtpase associated proteins |
| 06/02/2000 | WO2000031248A1 Humanized monoclonal antibodies |
| 06/02/2000 | WO2000031239A1 Immune cells having predefined biological specificity, comprising chimeric t cell receptor |
| 06/02/2000 | WO2000031141A1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 06/02/2000 | WO2000031130A1 Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications |
| 06/02/2000 | WO2000031127A2 Protein fragments for use in protein targeting |
| 06/02/2000 | WO2000031115A1 Methods of identifying antigen gene sequences |
| 06/02/2000 | WO2000030681A1 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases |